EFG Asset Management Americas Corp. Has $3.40 Million Stock Position in McKesson Corporation $MCK

Key Points

• EFG Asset Management Americas Corp. boosted its stake in McKesson by 385% in Q3, buying an additional 3,492 shares to hold 4,399 shares worth about $3.40 million.
• Institutional investors dominate ownership — 85.07% held by hedge funds and institutions, including Vanguard's 12.07 million shares (~$8.85B) and a new ~ $1.35B position from Norges Bank.
• EPS beat: McKesson reported $9.34 EPS (vs. $9.19 estimate) and $106.16B revenue (up 11.4%); it issued FY2026 guidance of $38.80–$39.20 EPS and carries a consensus target of $960.93 (Moderate Buy).

EFG Asset Management Americas Corp. increased its stake in McKesson Corporation (NYSE:MCK - Free Report) by 385.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,399 shares of the company's stock after purchasing an additional 3,492 shares during the quarter. EFG Asset Management Americas Corp.'s holdings in McKesson were worth $3,398,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently bought and sold shares of MCK. Norges Bank acquired a new position in shares of McKesson in the second quarter worth about $1,346,661,000. Alliancebernstein L.P. raised its holdings in shares of McKesson by 150.4% during the second quarter. Alliancebernstein L.P. now owns 2,268,015 shares of the company's stock valued at $1,661,956,000 after acquiring an additional 1,362,386 shares during the period. Arrowstreet Capital Limited Partnership lifted its position in shares of McKesson by 56.4% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,236,536 shares of the company's stock valued at $906,109,000 after acquiring an additional 446,060 shares in the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main boosted its stake in McKesson by 45.6% in the 2nd quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 833,780 shares of the company's stock worth $610,977,000 after purchasing an additional 261,296 shares during the period. Finally, Vanguard Group Inc. grew its position in McKesson by 2.0% during the 2nd quarter. Vanguard Group Inc. now owns 12,072,090 shares of the company's stock worth $8,846,186,000 after purchasing an additional 232,286 shares in the last quarter. 85.07% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other McKesson news, EVP Leann B. Smith sold 190 shares of the firm's stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total transaction of $179,550.00. Following the transaction, the executive vice president directly owned 2,989 shares in the company, valued at $2,824,605. This trade represents a 5.98% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Thomas L. Rodgers sold 276 shares of the business's stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $816.18, for a total value of $225,265.68. Following the completion of the sale, the executive vice president directly owned 2,268 shares of the company's stock, valued at $1,851,096.24. This represents a 10.85% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 3,868 shares of company stock valued at $3,743,820. Corporate insiders own 0.08% of the company's stock.

McKesson Stock Performance

NYSE:MCK opened at $941.51 on Friday. The company has a market capitalization of $115.32 billion, a P/E ratio of 27.08, a P/E/G ratio of 1.51 and a beta of 0.38. The stock's 50 day moving average price is $893.90 and its 200 day moving average price is $825.35. McKesson Corporation has a 52 week low of $637.00 and a 52 week high of $999.00.

McKesson (NYSE:MCK - Get Free Report) last posted its earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping the consensus estimate of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. During the same period in the previous year, the firm posted $8.03 earnings per share. The company's revenue for the quarter was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, sell-side analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be issued a $0.82 dividend. The ex-dividend date is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.3%. McKesson's dividend payout ratio is currently 9.43%.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on MCK shares. Zacks Research lowered McKesson from a "strong-buy" rating to a "hold" rating in a report on Tuesday, November 25th. Evercore reiterated an "outperform" rating on shares of McKesson in a report on Thursday, March 5th. Wall Street Zen downgraded McKesson from a "buy" rating to a "hold" rating in a research note on Saturday. Robert W. Baird set a $968.00 price objective on McKesson in a research report on Wednesday, January 14th. Finally, Raymond James Financial set a $970.00 target price on McKesson in a research note on Thursday, March 5th. Thirteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $960.93.

About McKesson

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.